بررسی اثرات درمانی سورفاکتانت در کاهش مرگ و میر نوزادان

Introduction & Objective: One of the standard therapies in neonates with severe respiratory distress syndrome (RDS) is surfactant administration in early course of therapy that cause reduction in mortality, pneumothorax and need to mechanical ventilation. In this study that was carried out in Aliasghar Hospital NICU in 1994-1995 & 2001-2002, the goal was to compare two groups of neonates with severe RDS that had been ventilated in the first 24 hours but one group had received surfactant and the other group (7 years ago) was deprived of this substance.    Materials & Methods: In our study, 36 neonates that received surfactant and 52 neonates with only mechanical ventilation therapy were compared. Data collected and analyzed using SPSS. Results: We found that mortality in patients with surfactant administration was significantly lower compared to the second group who did not receive surfactant. There were not any significant differences in incidences of HIV, pneumothorax,sepsis, and PDA and also course of hospitalization and need to ventilation between two groups.   Conclusion: As a result, all of these findings reflect obligatory surfactant administration in sever RDS in NICU under observation of an educated expert.